UPC News and Press, Universe Pharmaceuticals Inc From 01/31/22

Ji’an, Jiangxi, China, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2021. Mr. Gang La...

Ji’an, Jiangxi, China, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into two strategic cooperation agreements (the “A...

Ji’an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agre...

Universe Pharmaceuticals (NASDAQ:UPC) appointed Mr. Baochang Liu as its COO, effective Dec.1; Mr. Baochang Liu has 17+ years of experience in pharmaceutical marketing. Since 2019, he has been working as marketing and general manager of OTC department at China Shi...

Ji’an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointed Mr. Baochang Liu as its Chief Operating Officer,...

Galera Therapeutics (NASDAQ:GRTX) +138% announces primary endpoint met statistical significance in corrected topline efficacy data of phase 3 ROMAN trial of avasopasem. Nuverra Environmental Solutions (NYSE:NES) +33%. Terminix Global Holdings (NYSE:TMX) +25%. MIND Technology (NASDAQ:MIND...

Universe Pharmaceuticals (NASDAQ:UPC) entered into a strategic cooperation agreement and associated ancillary agreements with Kitanihon Pharmaceutical, a Japanese company engaged in the research, development, manufacturing, and distribution of Kampo pharmaceutical and medical products. T...

Ji’an, Jiangxi, China, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on December 1, 2021 the Company entered into a strategic cooperation agreement a...

ChemoCentryx CCXI +71% on FDA approval of Tavneos for treatment of vasculitis (updated) Camber Energy (NYSE:CEI) +33%. eFFECTOR Therapeutics EFTR +22% after-hours on encouraging zotatifin data in breast cancer InflaRx N.V. (NASDAQ:IFRX) +18%. Immuron (NASDAQ:IMRN) +16%. Fo...

Universe Pharmaceuticals (NASDAQ:UPC): 1H GAAP EPS of $0.44. Revenue of $24.3M (+48.2% Y/Y) As of March 31, 2021, the Company had cash of $36.0M as compared to $10.1M as of September 30, 2020. Press Release For further details see: Universe Pharmaceuticals reports 1H results